Related Experiment Video
Updated: Apr 11, 2026

Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
Evidence for Cerebral Hemodynamic Measurement-based Therapy in Symptomatic Major Cerebral Artery Disease
1Division of PET Imaging, Shiga Medical Centre Research Institute.
Insights
Strategies for treating atherosclerotic major cerebral artery disease with hemodynamic compromise remain unclear. Further research is needed to establish effective treatment selection based on hemodynamic measurements to reduce stroke risk.
Area of Science:
- Neurology
- Vascular Surgery
Background:
- Atherosclerotic internal carotid artery or middle cerebral artery occlusive disease can cause chronic hemodynamic compromise, increasing ischemic stroke risk.
- Current treatment strategies based on hemodynamic measurements are not well-established.
- The efficacy of bypass surgery and strict blood pressure control in reducing stroke risk in these patients is debated.
Purpose of the Study:
- To review the current evidence on managing atherosclerotic major cerebral artery disease with hemodynamic compromise.
- To highlight the need for established treatment strategies based on hemodynamic parameters.
Main Methods:
- Review of existing randomized controlled trials and observational studies.
- Analysis of hemodynamic parameters in patients with atherosclerotic disease.
Main Results:
- Bypass surgery has shown potential in improving hemodynamic compromise, but its stroke risk reduction benefit is controversial.
- Antihypertensive therapy offers general benefits, but the impact of strict blood pressure control on stroke risk in hemodynamic compromise is uncertain.
- Inconsistent results from existing trials indicate a need for further investigation.
Conclusions:
- There is a critical need to develop and validate treatment selection strategies guided by hemodynamic measurements for atherosclerotic major cerebral artery disease.
- Optimizing treatment based on individual hemodynamic profiles may improve stroke risk reduction.
Abstract:
In patients with atherosclerotic internal carotid artery or middle cerebral artery occlusive disease, chronic reduction in cerebral perfusion pressure (chronic hemodynamic compromise) increases the risk of ischemic stroke and can be detected by directly measuring hemodynamic parameters. However, strategies for selecting treatments based on hemodynamic measurements have not been clearly established. Bypass surgery has been proven to improve hemodynamic compromise. However, the benefit of bypass surgery for reducing the stroke risk in patients with hemodynamic compromise is controversial. The results of the two randomized controlled trials were inconsistent. Hypertension is a major risk factor for stroke, and antihypertensive therapy provides general benefit to patients with symptomatic atherosclerotic major cerebral artery disease. However, the benefit of strict control of blood pressure for reducing the stroke risk in patients with hemodynamic compromise is a matter of debate. The results of the two observational studies were different. We must establish strategies for selecting treatments based on hemodynamic measurements in atherosclerotic major cerebral artery disease.

